KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.75 $7.64 Friday, 26th Apr 2024 FATE stock ended at $3.80. This is 1.81% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $3.75 to a day high of $3.95.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Apr 12, 2016 $2.30 $2.32 $2.10 $2.12 279 125
Apr 11, 2016 $2.20 $2.37 $2.08 $2.24 402 046
Apr 08, 2016 $2.02 $2.29 $1.96 $2.14 869 460
Apr 07, 2016 $2.05 $2.09 $2.00 $2.01 79 806
Apr 06, 2016 $1.97 $2.10 $1.95 $2.04 170 787
Apr 05, 2016 $1.92 $1.99 $1.87 $1.96 71 795
Apr 04, 2016 $1.98 $2.15 $1.90 $1.94 217 003
Apr 01, 2016 $1.80 $2.00 $1.80 $1.95 281 689
Mar 31, 2016 $1.78 $1.90 $1.74 $1.80 150 714
Mar 30, 2016 $1.84 $1.90 $1.72 $1.72 71 101
Mar 29, 2016 $1.85 $1.89 $1.76 $1.82 100 500
Mar 28, 2016 $1.87 $1.93 $1.81 $1.85 123 300
Mar 24, 2016 $1.80 $1.96 $1.75 $1.88 108 500
Mar 23, 2016 $1.96 $2.09 $1.77 $1.80 195 100
Mar 22, 2016 $1.87 $2.15 $1.87 $1.99 253 700
Mar 21, 2016 $1.87 $1.92 $1.80 $1.88 185 300
Mar 18, 2016 $1.76 $1.84 $1.71 $1.83 108 800
Mar 17, 2016 $1.74 $1.80 $1.65 $1.74 99 700
Mar 16, 2016 $1.75 $1.78 $1.70 $1.72 114 700
Mar 15, 2016 $1.81 $1.81 $1.70 $1.73 174 600
Mar 14, 2016 $1.83 $1.88 $1.76 $1.81 89 200
Mar 11, 2016 $1.88 $1.88 $1.75 $1.82 139 100
Mar 10, 2016 $1.91 $1.93 $1.77 $1.84 142 400
Mar 09, 2016 $1.99 $2.01 $1.86 $1.92 98 000
Mar 08, 2016 $2.04 $2.11 $1.90 $1.95 235 100
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT